Pfizer, Novartis settle patent dispute over Zithromax
Pfizer and Novartis AG have settled a patent-infringement dispute filed in a U.S. court over Pfizer's Zithromax antibiotic. Novartis and one of its U.S. units, Sandoz, were named in the suit over Pfizer's claim to a 2005 patent for the drug, but the parties settled on undisclosed terms.
New York Times, The | 07/06
This story published in FDLI SmartBrief on 10/02/2007
More from SmartBrief:
Pfizer heads to trial over possible suicide risk in Neurontin
Friday, July 24, 2009
Former employee testifies against Pfizer in Neurontin lawsuit
Wednesday, July 29, 2009
Family dismisses liability lawsuit against Pfizer over Neurontin
Thursday, July 30, 2009
Get stories like these delivered daily for FREE:
|
FDLI SmartBrief
Designed specifically for professionals involved in the food and drug industry, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition. Learn more |
|